- $1.83bn
- $1.86bn
- $973.58m
- 89
- 94
- 83
- 99
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 447 | 462 | 690 | 993 | 974 |
Cost of Revenue | |||||
Gross Profit | 333 | 336 | 529 | 799 | 770 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 246 | 263 | 220 | 336 | 395 |
Operating Profit | 201 | 199 | 470 | 658 | 578 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 131 | 154 | 1,059 | 577 | 576 |
Provision for Income Taxes | |||||
Net Income After Taxes | 131 | 154 | 1,053 | 559 | 576 |
Net Income Before Extraordinary Items | |||||
Net Income | 131 | 154 | 1,053 | 559 | 576 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 131 | 154 | 1,053 | 559 | 576 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 8.09 | 6.47 | 45.8 | 25.3 | 29 |
Dividends per Share |